CLS Presents Image-Guided Laser Thermotherapy System at 30th Annual Prostate Cancer Update Conference
IRVINE, CA, January 24, 2020 - Clinical Laserthermia Systems Americas (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® ç Thermal Therapy System, new MRI-integrated thermometry software, and latest enhancements at the 30th Annual Prostate Cancer Update Conference this January 23-26, 2020 in Beaver Creek, Colorado. CLS’s innovative system enables minimally invasive treatments of tumors and soft tissues using MR or CT/US-guided procedures. Here are several Clinical Trial Results and Posters.
PROGRAM OVERVIEW
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. IPCU 30 will encompass expert lectures, interactive discussions, a panel roundtable, debates, and case reports. This conference is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer.
Dan Mogren, Chief Commercial Officer
P: +46 70-590 11 40
E: Dan.Mogren@clinicallaser.com
Clinical Laserthermia Systems AB (publ),develops and sells the TRANBERG®|Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immuno-stimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and has a subsidiary in Germany and Irvine, CA. is listed Nasdaq First North Growth Market under the ticker CLS B. Certified Adviser (CA) is FNCA Sweden AB, Ph: +46 8 528 00 399. E-mail: info@fnca.se.
Further information is available on www.clinicallaser.se.